22704 Federal Register / Vol. 70, No.
83 / Monday, May 2, 2005 / Notices
(6) An estimate of the total public
burden (in hours) associated with the
collection: The estimated total public
burden associated with the Web
submission form will be 19,200 hours
annually, while bulk data extraction is
estimated at 576 hours annually.
If additional information is required
contact: Brenda E. Dyer, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street NW.,
Washington, DC 20530.
Dated: April 27, 2005.
Brenda E. Dyer,
Department Clearance Officer, United States
Department of Justice.
[FR Doc. 05–8680 Filed 4–29–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on February 18,
2005, Lilly Del Caribe, Inc., Chemical
Plant, Kilometer 146.7, State Road 2,
Mayaguez, Puerto Rico 00680, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Dextropropoxyphene (9273), a basic
class of controlled substance listed in
Schedules II.
The company plans to manufacture
the listed controlled substance in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than July 1, 2005.
VerDate jul<14>2003 19:05 Apr 29, 2005 Jkt 205001
Dated: April 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–8694 Filed 4–29–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on January 5,
2005, Roche Diagnostics Operations
Inc., Attn: Regulatory Compliance, 9115
Hague Road, Indianapolis, Indiana
46250, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
Drug
Lysergic Acid Diethylamide (7315)
Tetrahydrocannabinol (7370) .......
Alphamethadol (9605) ..................
Phencyclidine (7471) ....................
Benzoylecgonine (9180) ...............
Methadone (9250) ........................
Morphine (9300) ...........................
The company plans to manufacture
small quantities of the listed controlled
substances for use in diagnostic
products.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than July 1, 2005.
PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\02MYN1.SGM
Dated: April 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–8693 Filed 4–29–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Federal Bureau of Investigation
Agency Information Collection
Activities: Proposed Collection;
Comments Requested
ACTION: 30-Day Notice of Information
Collection Under Review: Voluntary
Appeal File (VAF) Brochure.
The Department of Justice (DOJ),
Federal Bureau of Investigation (FBI)
has submitted the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
Schedule proposed information collection was
previously published in the Federal
I Register Volume 69, Number 218, page
I
65455 on November 12, 2004, allowing
I for a 60 day comment period.
II The purpose of this notice is to allow
II for an additional 30 days for public
II comment until June 1, 2005. This
II process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–5806. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agencies
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
02MYN1